Much has been written about the recent explosion of biotech IPOs, and last week they accounted for seven of the ten IPOs that priced. Together, they had an average deal size of less than $70 million, and averaged a 16% return. Revance (RVNC), a biotech...read more
GeoPark, an oil and natural gas E&P operating in Chile, Colombia and Brazil, raised $95 million by offering 13.5 million shares at $7, the low end of its downwardly revised range. The company had previously filed to offer 20.0 million shares at a range of $8...read more
GeoPark, an oil and natural gas E&P operating in Chile, Colombia and Brazil, lowered the proposed deal size for its upcoming IPO on Thursday. The Santiago, Chile-based company now plans to raise $101 million by offering 13.5 million shares at a price range...read more
US IPO Recap: Revance jumps 68% in ten-IPO week
Much has been written about the recent explosion of biotech IPOs, and last week they accounted for seven of the ten IPOs that priced. Together, they had an average deal size of less than $70 million, and averaged a 16% return. Revance (RVNC), a biotech...read more
South American E&P GeoPark prices IPO at $7, low end of the revised range
GeoPark, an oil and natural gas E&P operating in Chile, Colombia and Brazil, raised $95 million by offering 13.5 million shares at $7, the low end of its downwardly revised range. The company had previously filed to offer 20.0 million shares at a range of $8...read more
South American E&P GeoPark decreases range to $7 to $8, drops shares offered by 33%
GeoPark, an oil and natural gas E&P operating in Chile, Colombia and Brazil, lowered the proposed deal size for its upcoming IPO on Thursday. The Santiago, Chile-based company now plans to raise $101 million by offering 13.5 million shares at a price range...read more
12 US IPOs planned for the week of Feb 3
The following IPOs are expected to price this week: Argos Therapeutics (ARGS), which is developing immunotherapies for the treatment of cancer and HIV, plans to raise...read more